Skip to content

Change in AR at other companies

Amgen logo
AmgenAMGN
-$413M-132%
Nuvation Bio logo
Nuvation BioNUVB
$6.65M+154%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$1.49M-212%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$3.42M-106%
Incyte logo
IncyteINCY
$27.03M+187%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$6.5M+110%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: IDEAYA Biosciences, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s change in AR?
IDEAYA Biosciences, Inc. (IDYA) reported change in AR of -$0 in Q4 2025.
How has IDEAYA Biosciences, Inc.'s change in AR changed year-over-year?
IDEAYA Biosciences, Inc.'s change in AR increased by 100.0% year-over-year, from -$2K to -$0.
What is the long-term trend for IDEAYA Biosciences, Inc.'s change in AR?
Over 3 years (2022 to 2025), IDEAYA Biosciences, Inc.'s change in AR has grown at a -100.0% compound annual growth rate (CAGR), from -$892K to $0.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.